Skip to main navigation menu Skip to main content Skip to site footer

Utility of bronchoalveolar lavage in diagnosing ventilator-associated pneumonia

Utilidad del lavado broncoalveolar en el diagnóstico de la neumonía asociada a la ventilación mecánica




Section
Topics review

How to Cite
Utility of bronchoalveolar lavage in diagnosing ventilator-associated pneumonia.
rev. colomb. neumol. [Internet]. 2016 Mar. 30 [cited 2024 Nov. 23];28(1):33-8. Disponible en: https://doi.org/10.30789/rcneumologia.v28.n1.2016.162

Dimensions
PlumX
license

Ninguna publicación, nacional o extranjera, podrá reproducir ni traducir sus artículos ni sus resúmenes sin previa autorización escrita del editor; sin embargo  los usuarios pueden descargar la información contenida en ella, pero deben darle atribución o reconocimiento de propiedad intelectual, deben usarlo tal como está, sin derivación alguna.

Guillermo Ortiz, MD.
    Antonio Lara García, MD.
      Manuel Garay Fernández, MD.

        Guillermo Ortiz, MD.,

        Internista, Neumólogo, Intensivista. Jefe Unidad de Cuidado Intensivo. Hospital Santa Clara. Bogotá, Colombia.


        Antonio Lara García, MD.,

        Internista, Neumólogo, Intensivista. Unidad Cuidado Intensivo. Hospital Santa Clara. Bogotá, Colombia.


        Manuel Garay Fernández, MD.,

        Internista, Neumólogo. Unidad Cuidado Intensivo. Hospital Santa Clara. Bogotá, Colombia.


        Ventilator-associated pneumonia is the main cause of infection and death in the intensive care unit. Its diagnosis implies the presence of systemic signs of infection, new or worsened pulmonary infiltrates, and positive bacteriologic tests; however, these are non-specific characteristics that may be caused by multiple circumstances in the critically ill patient. Moreover, late or inadequate initiation of antibiotic therapy also worsens the prognosis and outcome of ventilator-associated pneumonia, and therefore microbiologic information is of vital importance for reducing the gap of empirical treatment.

        One invasive technique for obtaining samples of the lower respiratory tract is bronchoscopy with bronchoalveolar lavage or protected brush. Samples are processed to obtain quantitative isolation of germs. Non-bronchoscopic techniques have also been described, including endotracheal aspiration and mini-bronchoalveolar lavage; the cut-points of these techniques, in order that they may be considered positive, are different. The decision concerning the best method for obtaining samples for diagnosing ventilator-associated pneumonia is still controversial, and until now none of them has proven to be superior. At any rate, it is advisable to use the technique that may be readily performed in each center by experienced practitioners who are familiar with the technique. Early and adequate therapy for the management of ventilator-associated pneumonia has shown its importance in many studies that are analyzed in this article. Judicious interpretation of culture results should lead to de-escalation of antibiotic therapy, in order to comply with policies concerning adequate antibiotic use and reduction of mortality.


        Article visits 3204 | PDF visits 2543


        Downloads

        Download data is not yet available.
        1. Wunderink RG, Woldenberg LS, Zeiss J, Day CM, Ciemins J, Lacher DA. The radiologic diagnosis of autopsy-proven ventilator-associated pneumonia. Chest. 1992;101(2):458.
        2. Andrews CP, Coalson JJ, Smith JD, Johanson WG Jr. Diagnosis of nosocomial bacterial pneumonia in acute diffuse lung injury. Chest. 1981;80(3):254.
        3. American Thoracic Society. Infectious Diseases Society of America Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med.2005;171(4):388.
        4. Rubin SA, Winer-Muram HT, Ellis JV. Diagnostic imaging of pneumonia and its complications in the critically ill patient. Clin Chest Med. 1995;16(1):45.
        5. Kollef MH. What is ventilator associated pneumonia and why is it important? Respiratoy Care. 2005;50:714-21.
        6. Iregui M, Ward S, Sherman G, Fraser VJ, Kollef MH. Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia. CHEST. 2002;122(1):262-8.
        7. Luna CM, Aruj P, Niederman MS, Garzón J, Grupo Argentino de Estudio de la Neumonía Asociada al Respirador (GANAR) group Appropriateness and delay to initiate therapy in ventilator-associated pneumonia. Eur Respir J. 2006;27:158-64.
        8. Kollef MH, Fraser VJ. Antibiotic resistance in the intensive care unit. Ann Intern Med. 2001;134(4):298-314.
        9. Torres A, El-Ebiary M. Bronchoscopic BAL in the diagnosis of ventilator-associated pneumonia. Chest. 2000;117:198S-202S.
        10. de Jaeger A, Litalien C, Lacroix J. Protected specimen brush or bronchoalveolar lavage to diagnose bacterial nosocomial pneumonia in ventilated adults: A meta-analysis. Critical Care Medicine. 1999;27(11):2548-60.
        11. Lim W, Baudouin S, George R, Hill A, Jamieson C, Jeune I, et al. British Thoracic Society guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax. 2009; 64 (Suppl III):iii1–iii55.
        12. Fagon JY, Chastre J, Wolff M, Gervais C, Parer-Aubas S, Stéphan F, Invasive and noninvasive strategies for management of suspected ventilator-associated pneumonia. A randomized trial. Ann Intern Med. 2000;132(8):621-30.
        13. Sanchez-Nieto JM, Torres A, Garcia-Cordoba F, El-Ebiary M, Carrillo A, Ruiz J, Nuñez ML, Niederman M. Impact of invasive and noninvasive quantitative culture sampling on outcome of ventilator-associated pneumonia: a pilot study. Am J Respir Crit Care Med. 1998;157:371-6.
        14. Shorr AF, Sherner JH, Jackson WL, Kollef MH. Invasive approaches to the diagnosis of ventilator-associated pneumonia: a meta-analysis. Crit Care Med. 2005;33(1):46-53.
        15. Ruiz M, Torres A, Ewig S. Noninvasive Versus Invasive Microbial Investigation in Ventilator-associated Pneumonia: Evaluation of Outcome. Am J Respir Crit Care Med. 2000;162:119-25.
        16. Solé Violán J, Fernández JA, Benítez AB, Cardeñosa Cendrero JA, Rodríguez de Castro F. Impact of quantitative invasive diagnostic techniques in the management and outcome of mechanically ventilated patients with suspected pneumonia. Crit Care Med. 2000 Aug;28(8):2737-41.
        17. Alvarez-Lerma F. Modification of empiric antibiotic treatment in patients with pneumonia acquired in the intensive care unit. Int Care Med. 1996;22(5):387-94.
        18. Luna CM, Vujacich P, Niederman MS, Vay C, Gherardi C, Matera J, Jolly EC. Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia. Chest. 1997; 111(3):676-85.
        19. Canadian Critical Care Trials Group. A randomized trial of diagnostic techniques for ventilator-associated pneumonia. N Engl J Med. 2006; 355(25):2619-30.
        20. Ortiz G, Garay M, Fonseca N, Molina F, Lara A, Dueñas C, Epidemiología de la neumonía asociada a ventilador en 39 unidades de cuidados intensivos de Colombia (2007-2009). Informe año 2010. Act Colomb Cuidado Int. 2011;11(1):12-9.
        21. Hoffken G, Niederman MS. Nosocomial pneumonia: the importance of a de-escalating strategy for antibiotic treatment of pneumonia in the ICU. Chest. 2002;122:2183–96.
        22. O’Horo J, Thompson D, Safdar N. Is the Gram Stain Useful in the Microbiologic Diagnosis of VAP? A Meta-analysis. Clin Infect Dis. 2012;55(4):551–61.
        23. Berton DC, Kalil AC, Teixeira PJ. Quantitative versus qualitative cultures of respiratory secretions for clinical outcomes in patients with ventilator-associated pneumonia. Cochrane Database Syst Rev. 2012;1:CD006482.
        24. Soo Hoo GW, Wen E, Nguyen TV, Goetz MD. Impact of clinical guidelines in the management of severe hospital-acquired pneumonia. Chest. 2005;128:2778–87.
        25. Rello J, Vidaur L, Sandiumenge A, et al. De-escalation therapy in ventilator associated pneumonia. Crit Care Med. 2004;32:2183-90.
        26. Kollef MH, Morrow LE, Niederman MS, et al. Clinical characteristics and treatment patterns among patients with ventilator-associated pneumonia. Chest. 2006;129:1210–8.
        27. Rea-Neto A, Tuche F, Brunkhorst F, Ranieri M, Reinhart K, Sakr Y. Diagnosis of ventilator-associated pneumonia: a systematic review of the literature. Crit Care. 2008;12:R56.
        28. Chastre J, Fagon JY, Bornet-Lecso M, et al. Evaluation of bronchoscopic techniques for the diagnosis of nosocomial pneumonia. Am J Respir Crit Care Med. 1995;152:231–40.
        29. Marquette CH, Georges H, Wallet F, et al. Diagnostic efficiency of endotracheal aspirates with quantitative bacterial cultures in intubated patients with suspected pneumonia. Comparison with the protected specimen brush. Am Rev Respir Dis. 1993;148:138–44.
        30. Fagon JY, Chastre J, Domart Y et al. Nosocomial pneumonia in patients receiving continuous mechanical ventilation. Prospective analysis of 52 episodes with use of a protected specimen brush and quantitative culture techniques. Am Rev Respir Dis. 1989;139:877-84.
        31. Torres A, Puig de la BJ, Xaubet A, et al. Diagnostic value of quantitative cultures of bronchoalveolar lavage and telescoping plugged catheters in mechanically ventilated patients with bacterial pneumonia. Am Rev Respir Dis.1989;140:306-10.
        32. Garnacho-Montero J, Gutiérrez-Pizarraya A, Escoresca-Ortega A, Corcia-Palomo Y, Fernández-Delgado E, Herrera-Melero I, et al. De-escalation of empirical therapy is associated with lower mortality in patients with severe sepsis and septic shock. Int Care Med. 2014;40(1):32-40.
        33. Joung MK, Lee JA, Moon SY, Cheong HS, Joo EJ, Ha YE, et al. Impact of de-escalation therapy on clinical outcomes for intensive care unit-acquired pneumonia. Crit Care. 2011;15(2):R79.
        34. Berton D, Kalil AC, Teixeira P. Quantitative versus qualitative cultures of respiratory secretions in patients with ventilator-associated pneumonia. Cochrane Database Syst Rev. 2014;30(10):CD006482.
        Sistema OJS 3.4.0.7 - Metabiblioteca |